GMP: GDUFA: New Fee Act for the Generic Drugs and APIs Industry adopted by the Congress

The US Congress passed the so-called \"Generic Drug User Fee Act\" (GDUFA). This act allows the FDA to charge Generic Drug companies who submit a marketing authorisation application for generics (Abbreviated New Drug Application; ANDA), a variation application or a Drug Master File.